General Discussion Topics, page-89

Too Easy !!
All of the above..
Regarding approval: They have already Failed
Twice. This is their third attempt.
They have had 41/2 years trying.
Nice to have these so called shelf life ( longer)
Temperature range greater . Pure Mithra
Fornieri sales pitch. A Generic is exactly that
a Generic. Identical !!!!!
So Price is your only sales advantage.
I never said FDA wouldn’t approve.
The only Generic manufacturing winner is
first to market. ( Obviously )
Dont forget Merck have their own Generic
which is Nuvaring in different packaging.
Cost for Mayne has been 41/2 years of wasted
bloody time and Carrot Dangling!!
There must also be R and D . Some of their 900
staff costs. ( Who really knows ???
My valuation for Myring now is Zip
It may assist as another of Maynes contraceptive
products in Bundle sales. We were Number 2 in USA
Now 3-4 . Also Krugerrand I just read your profits
min 2% market share.
Your Maths I can’t quite follow. Your sums are
close but not precise.
You obviously have recently invested and arnt
min negative territory Good for you. But truly
Krugs FF from Mithra will probably be sentenced
to prison . This is the same guy who dealt with our
CEO. Let’s face the facts if Nextellis was the next
big thing after 50 years of contraceptives why
seriously would you appoint MYX as your
Distributor in US. They had more to gain from
Mayne than the reverse.